Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Chiron's strategy in U.K. patent dispute

Chiron Corp. has won a court case that justifies the calculated risk it took in planning the global protection of its hepatitis C patent estate.

A British court last week upheld the key portions of the company's HCV patent in a suit brought in 1992 by CHIR and its joint diagnostic business partners, Ortho Diagnostic Systems Inc. and Ortho Diagnostic Systems Ltd., against Organon Teknika Ltd. and Murex

Read the full 681 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE